Synapse - Works

Results (589)

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study

Journal Article

Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
Lancet (2024)

Fulltext@MSK | Save

Alpha-emitting radionuclides: Current status and future perspectives

Review

Miederer, M.; Benešová-Schäfer, M.; Mamat, C.; Kästner, D.; Pretze, M.; Michler, E.; Brogsitter, C.; Kotzerke, J.; Kopka, K.; Scheinberg, D. A.; more...
Pharmaceuticals (2024)

Fulltext@MSK | Save

Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer

Journal Article

Comen, E.; Budhu, S.; Elhanati, Y.; Page, D.; Rasalan-Ho, T.; Ritter, E.; Wong, P.; Plitas, G.; Patil, S.; Brogi, E.; more...
iScience (2024)

Fulltext@MSK | Save

Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: Overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs

Editorial

Bodei, L.; Tuttle, R. M.; Grewal, R. K.; Mauguen, A.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J. R.; Haque, S.; more...
European Journal of Nuclear Medicine and Molecular Imaging (2024)

Fulltext@MSK | Save

Phase I study of paxalisib and radiotherapy for CNS disease harboring PI3K pathway mutations: Pilot analysis of circulating tumor DNA for patient eligibility confirmation and post-treatment response

Meeting Abstract

Imber, B.; Ravichandran, V.; Rao, P.; Casanova, H.; Friend, J.; Simpson, J.; Pike, L.; Zinovoy, M.; Mitchell, R.; Chacko, C.; more...
Neuro-Oncology (2023)

Fulltext@MSK | Save

Phase I dose escalation trial combining olaparib and thoracic radiation therapy in extensive-stage small cell lung cancer

Meeting Abstract

Rimner, A.; Lok, B.; Gelblum, D. Y.; Kotecha, R. R.; Albrecht, F.; Shin, J. Y.; Laplant, Q.; Namakydoust, A.; Shepherd, A.; Gomez, D.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Prospective comparison of F-18-TFB and I-124 PET/CT in metastatic thyroid cancer

Meeting Abstract

Backhaus, P.; Pentlow, K.; Ho, A.; Mauguen, A.; Fagin, J.; Pillarsetty, N. V. K.; Lyashchenko, S.; Abusamra, M.; Larson, S.; Schoder, H.; more...
Journal of Nuclear Medicine (2023)

Fulltext@MSK | Save

Pretargeted radioimmunotherapy with (212)Pb-DOTA-based haptens in nude mice bearing established human-colorectal xenografts

Meeting Abstract

Vaughn, B.; Veach, D.; Vargas, D. B.; Punzalan, B.; Zanzonico, P.; Xu, H.; Guo, H. F.; Yang, G.; Ouerfelli, O.; Cheung, N. K.; more...
Journal of Nuclear Medicine (2023)

Fulltext@MSK | Save

Tumor immune microenvironment determinants of response to lenvatinib and a PD-1 blockade in clear cell renal cell carcinoma

Meeting Abstract

Vuong, L.; Kuo, F.; Jiang, H.; Mascareno, E. A.; Rappold, P.; Sabio, E.; Weiss, K.; Cornish, A.; Reese, S.; Adlesic, M.; more...
Cancer Research (2023)

Fulltext@MSK | Save

Efficacy of HER2-targeted intraperitoneal (225)Ac α-pretargeted radioimmunotherapy for small-volume ovarian peritoneal carcinomatosis

Journal Article

Chung, S. K.; Vargas, D. B.; Chandler, C. S.; Katugampola, S.; Veach, D. R.; McDevitt, M. R.; Seo, S. H.; Vaughn, B. A.; Rinne, S. S.; Punzalan, B.; more...
Journal of Nuclear Medicine (2023)

Fulltext@MSK | Save